SARS-CoV-2 3CLpro-IN-35 is an inhibitor of the SARS-CoV-2 3CL protease, exhibiting an IC50 of 0.15 μM. This compound demonstrates potent anti-SARS-CoV-2 activity and effectively inhibits the proliferation of bladder cancer cells while maintaining low cytotoxicity in fibroblasts. It is suitable for research applications focused on SARS-CoV-2 infection and bladder cancer treatment strategies.
SARS-CoV-2 3CLpro-IN-35 is an inhibitor of the SARS-CoV-2 3CL protease, exhibiting an IC50 of 0.15 μM. This compound demonstrates potent anti-SARS-CoV-2 activity and effectively inhibits the proliferation of bladder cancer cells while maintaining low cytotoxicity in fibroblasts. It is suitable for research applications focused on SARS-CoV-2 infection and bladder cancer treatment strategies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
